mAb/Recombinant Protein Lot Release Package

WuXi Advanced Therapies offers reliable lot release testing for your monoclonal antibodies (mAb) and recombinant proteins. With over 20 years of experience in bioanalytical testing, we are the experts you can trust.

Our comprehensive testing package includes assays to detect adventitious agents, assess general characteristics, and ensure compliance with cGMP regulations. From sterility and bioburden to color and appearance, WuXi Advanced Therapies covers it all. We understand the importance of timely testing and have served over 140 advanced therapy clients, including commercial lot release programs.

Operating from our state-of-the-art facility in Philadelphia, Rouse 400 (R400), WuXi Advanced Therapies has obtained regulatory approvals from regulatory organizations including the EMA, TGA, Health Canada, and FDA. Your lot release testing will be conducted with the highest standards of quality and accuracy.

Not only do we provide lot release testing, but WuXi Advanced Therapies also offers support for cell banking, viral clearance studies, and characterization testing throughout the product lifecycle. With a team of project managers and scientific experts on hand, we are ready to assist you every step of the way. Don't miss out on this opportunity to ensure the quality and safety of your mAb and recombinant protein products.